Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer

NCT01273402 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped A new study is being designed. No patients were enrolled.

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: TF2/IMP288

Sponsor

Gilead Sciences

Collaborators

[object Object]